Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

被引:1020
|
作者
Liu, Jiaqi [1 ]
Xiao, Qing [1 ]
Xiao, Jiani [1 ]
Niu, Chenxi [1 ]
Li, Yuanyuan [1 ]
Zhang, Xiaojun [1 ]
Zhou, Zhengwei [1 ]
Shu, Guang [1 ,2 ]
Yin, Gang [1 ,3 ]
机构
[1] Cent South Univ, Sch Basic Med Sci, Xiangya Hosp, Dept Pathol, Changsha 410013, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Histol & Embryol, Changsha 410013, Peoples R China
[3] Cent South Univ, Sch Basic Med Sci, China Africa Res Ctr Infect Dis, Changsha 410013, Peoples R China
关键词
PLURIPOTENT STEM-CELLS; HUMAN COLON-CANCER; BETA-CATENIN; COLORECTAL-CANCER; UP-REGULATION; BONE MASS; HEPATOCELLULAR CARCINOMAS; WNT/WINGLESS PATHWAY; INCREASED EXPRESSION; ALVEOLAR PROGENITOR;
D O I
10.1038/s41392-021-00762-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wnt/beta-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/beta-catenin signalling often leads to various serious diseases, including cancer and non-cancer diseases. Although many articles have reviewed Wnt/beta-catenin from various aspects, a systematic review encompassing the origin, composition, function, and clinical trials of the Wnt/beta-catenin signalling pathway in tumour and diseases is lacking. In this article, we comprehensively review the Wnt/beta-catenin pathway from the above five aspects in combination with the latest research. Finally, we propose challenges and opportunities for the development of small-molecular compounds targeting the Wnt signalling pathway in disease treatment.
引用
收藏
页数:23
相关论文
共 50 条
  • [32] β-catenin and wnt signalling partners in oral cancer
    Papagerakis, S.
    Papagerakis, P.
    Slaga, T.
    Fearon, E.
    Carey, T. E.
    ORAL ONCOLOGY, 2007, : 64 - 64
  • [33] Anabolic Wnt/β-catenin signalling: osteocytes are key
    Jenny Buckland
    Nature Reviews Rheumatology, 2015, 11 (3) : 128 - 128
  • [34] The Wnt/β-catenin signalling pathway in Haematological Neoplasms
    Siwei Yu
    Ruyue Han
    Runliang Gan
    Biomarker Research, 10
  • [35] Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities
    Dricu, Anica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [36] WNT/β-CATENIN SIGNALLING IS A POTENTIAL THERAPEUTIC TARGET FOR CASTRATE-RESISTANT PROSTATE CANCER.
    Kawano, Yoshiaki
    Maeda, Yoshihiro
    Motoshima, Takanobu
    Imamura, Takahisa
    Takahashi, Wataru
    Wada, Yoshihiro
    Kypta, Robert
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E504 - E505
  • [37] Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications
    Akoumianakis, Ioannis
    Polkinghorne, Murray
    Antoniades, Charalambos
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (12) : 783 - 797
  • [38] Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications
    Ioannis Akoumianakis
    Murray Polkinghorne
    Charalambos Antoniades
    Nature Reviews Cardiology, 2022, 19 : 783 - 797
  • [39] A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling
    Imajo, Masamichi
    Miyatake, Koichi
    Iimura, Akira
    Miyamoto, Atsumu
    Nishida, Eisuke
    EMBO JOURNAL, 2012, 31 (05): : 1109 - 1122
  • [40] Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
    McCubrey, J. A.
    Steelman, L. S.
    Bertrand, F. E.
    Davis, N. M.
    Abrams, S. L.
    Montalto, G.
    D'Assoro, A. B.
    Libra, M.
    Nicoletti, F.
    Maestro, R.
    Basecke, J.
    Cocco, L.
    Cervello, M.
    Martelli, A. M.
    LEUKEMIA, 2014, 28 (01) : 15 - 33